Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Seth Loring Harrison currently holds 26,000 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seth Loring Harrison has been a net seller of AKRO stock. They have purchased $75.5M and sold $126.4M worth of shares.
Seth Loring Harrison's most recent insider trade was on Dec 9, 2025, when they sold 9,398 shares at $0.00 per share.
Seth Loring Harrison serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 122 insider transactions totaling $202.0M over their tenure at the company.
Seth Loring Harrison holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Seth Loring Harrison has shown a selling trading pattern, with $75.5M in total purchases and $126.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Seth Loring Harrison was on Jun 21, 2019, when they purchased $25.0M worth of STOK shares. This transaction involved 1,388,889 shares at $18.00 per share.
Seth Loring Harrison currently owns 26,000 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Seth Loring Harrison's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Seth Loring Harrison has 122 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Seth Loring Harrison and 40,000+ other insiders.